397 related articles for article (PubMed ID: 10842891)
21. Glucocorticoid excess syndromes causing hypertension.
Krakoff LR
Cardiol Clin; 1988 Nov; 6(4):537-45. PubMed ID: 3067845
[TBL] [Abstract][Full Text] [Related]
22. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid-induced osteoporosis: an update.
Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
[TBL] [Abstract][Full Text] [Related]
24. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
[TBL] [Abstract][Full Text] [Related]
25. [Glucocorticoids and osteoporosis].
Zikán V
Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-induced osteoporosis.
Reid IR
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):279-98. PubMed ID: 11035907
[TBL] [Abstract][Full Text] [Related]
27. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
Nakayama H
Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
[TBL] [Abstract][Full Text] [Related]
28. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
Soen S
Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
[TBL] [Abstract][Full Text] [Related]
29. [Glucocorticoid induced osteoporosis].
Gutiérrez-Polo R
An Sist Sanit Navar; 2003; 26 Suppl 3():63-80. PubMed ID: 14716359
[TBL] [Abstract][Full Text] [Related]
30. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid induced risk of fractures.
Maruotti N; Corrado A; Cantatore FP
Panminerva Med; 2010 Dec; 52(4):339-43. PubMed ID: 21183894
[TBL] [Abstract][Full Text] [Related]
33. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
Hopkins RL; Leinung MC
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
[TBL] [Abstract][Full Text] [Related]
35. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
36. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
37. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
38. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
Takayanagi R
Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
[TBL] [Abstract][Full Text] [Related]
39. [Medical prophylaxis and treatment of steroid induced osteoporosis].
Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
[TBL] [Abstract][Full Text] [Related]
40. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
Blair MM; Carson DS; Barrington R
J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
